In vitro assessment of various cytochromes P450 and glucuronosyltransferases using the antiarrhythmic propafenone as a probe drug

被引:8
作者
Kroemer, HK
Botsch, S
Heinkele, G
Schick, M
机构
来源
CYTOCHROME P450, PT B | 1996年 / 272卷
关键词
D O I
10.1016/S0076-6879(96)72012-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:99 / 105
页数:7
相关论文
共 14 条
[1]   THE INFLUENCE OF ENVIRONMENTAL AND GENETIC-FACTORS ON CYP2D6, CYP1A2 AND UDP-GLUCURONOSYLTRANSFERASES IN MAN USING SPARTEINE, CAFFEINE, AND PARACETAMOL AS PROBES [J].
BOCK, KW ;
SCHRENK, D ;
FORSTER, A ;
GRIESE, EU ;
MORIKE, K ;
BROCKMEIER, D ;
EICHELBAUM, M .
PHARMACOGENETICS, 1994, 4 (04) :209-218
[2]  
BOTSCH S, 1994, EUR J CLIN PHARMACOL, V46, P133
[3]  
BOTSCH S, 1993, MOL PHARMACOL, V43, P120
[4]  
FUNCKBRENTANO C, 1990, NEW ENGL J MED, V322, P518
[5]  
HEINKELE G, UNPUB
[6]   AN ENANTIOMER-ENANTIOMER INTERACTION OF (S)-PROPAFENONE AND (R)-PROPAFENONE MODIFIES THE EFFECT OF RACEMIC DRUG-THERAPY [J].
KROEMER, HK ;
FROMM, MF ;
BUHL, K ;
TEREFE, H ;
BLASCHKE, G ;
EICHELBAUM, M .
CIRCULATION, 1994, 89 (05) :2396-2400
[7]   INVITRO CHARACTERIZATION OF THE HUMAN CYTOCHROME-P-450 INVOLVED IN POLYMORPHIC OXIDATION OF PROPAFENONE [J].
KROEMER, HK ;
MIKUS, G ;
KRONBACH, T ;
MEYER, UA ;
EICHELBAUM, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) :28-33
[8]  
KROEMER HK, 1991, MOL PHARMACOL, V40, P135
[9]  
KROEMER HK, 1993, N-S ARCH PHARMACOL, V348, P332
[10]   IDENTIFICATION OF PROPAFENONE METABOLIZER PHENOTYPE FROM PLASMA AND URINE EXCRETION DATA [J].
LATINI, R ;
BELLONI, M ;
BERNASCONI, R ;
CAPPIELLO, E ;
GIANI, P ;
LANDOLINA, M ;
LEOPALDI, D ;
CASTEL, JM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (01) :111-114